Yes, Initiate Oral Corticosteroids for This COPD Exacerbation
For a patient with COPD experiencing an acute exacerbation with wheezing, cough, and dyspnea on exertion, you should start oral corticosteroids immediately. This represents a moderate exacerbation requiring systemic corticosteroid therapy in addition to bronchodilators 1.
Treatment Rationale
Systemic corticosteroids improve lung function (FEV1), oxygenation, shorten recovery time, and reduce treatment failure rates in COPD exacerbations 1. The evidence demonstrates that corticosteroids reduce treatment failure by over half compared to placebo (OR 0.48), meaning you need to treat only 9 patients to prevent one treatment failure 2. They also reduce relapse rates by one month (HR 0.78) and shorten hospital stays by approximately 1.2 days 2.
Specific Dosing Recommendations
Give oral prednisolone 30-40 mg daily for 5 days 1, 3, 4. This short-duration regimen (5-7 days) is equally effective as longer courses (10-14 days) but minimizes adverse effects 4. The evidence is clear that:
- Oral administration is as effective as IV in patients not requiring ICU-level care 5, 3
- Five days is sufficient - no benefit from extending beyond 7 days 4
- No tapering is necessary for short courses 3
Clinical Decision Points
This patient's presentation with wheezing, cough, and dyspnea on exertion meets criteria for a moderate exacerbation by GOLD classification, which specifically requires treatment with short-acting bronchodilators PLUS oral corticosteroids and/or antibiotics 1.
Consider Blood Eosinophils If Available
If blood eosinophil counts are available, patients with elevated eosinophils (typically >300 cells/μL) show enhanced response to corticosteroids 1, 6. However, do not delay treatment waiting for eosinophil results in symptomatic patients.
Antibiotic Consideration
Assess for purulent sputum production. If present, add antibiotics as this predicts bacterial infection and improved antibiotic response 5.
Important Caveats
Monitor for hyperglycemia - the risk increases significantly with corticosteroid treatment (OR 2.79 for oral, OR 4.89 for IV) 2, 5. Check blood glucose in diabetic patients or those at risk.
The number needed to harm is approximately 5-6 patients for any adverse event 2, 7, but the benefits in reducing treatment failure and preventing relapse outweigh these risks in acute exacerbations.
Concurrent Management
- Start or optimize short-acting bronchodilators (beta-agonists with or without anticholinergics) immediately 1
- Ensure patient is on or will be started on long-acting bronchodilator maintenance therapy before discharge 1
- Assess oxygen saturation - new or worsening hypoxia requires hospital admission 8
Do not use methylxanthines due to unfavorable side effect profile 1.